How to Get Prometrium in South Carolina

At a glance
- Drug / micronized progesterone (Prometrium), oral capsule, 100 mg or 200 mg
- Manufacturer / Solvay Pharmaceuticals, now marketed by AbbVie
- Indication / endometrial protection in women on estrogen-based HRT with an intact uterus
- Standard dose / 200 mg once daily at bedtime for 12 days per cycle, or 100 mg nightly continuously
- Telehealth prescribing in SC / permitted under South Carolina law for established and new patients via synchronous audio-video consult
- Compounding access / licensed 503A pharmacies in South Carolina may compound micronized progesterone capsules
- SC Medicaid coverage / not covered for the HRT-endometrial-protection indication
- Labs needed / baseline FSH, estradiol, progesterone, CBC, LFTs recommended before initiation
- Transfer prescriptions / yes, an out-of-state Prometrium Rx can be transferred to a SC-licensed pharmacy
- Cost without insurance / approximately $60-$120 per 30-day supply at major SC retail chains
What Prometrium Is and Why the Uterus Matters
Prometrium is the brand-name formulation of micronized progesterone, a bioidentical progestogen that is chemically identical to endogenous progesterone. The FDA approved it for endometrial protection in postmenopausal women receiving conjugated estrogen therapy, based in part on data from the landmark Postmenopausal Estrogen/Progestin Interventions (PEPI) trial published in JAMA in 1995 [1].
Why Progesterone Is Paired With Estrogen
Estrogen-only therapy in women who still have a uterus raises the risk of endometrial hyperplasia and carcinoma. The PEPI trial (N=875, 3-year duration) found that unopposed conjugated estrogen produced endometrial hyperplasia in 62% of participants, compared with rates below 4% in women randomized to cyclic or continuous micronized progesterone [1]. That single statistic explains why every current guideline from the Menopause Society (formerly NAMS) requires a progestogen for any woman with an intact uterus who uses systemic estrogen [2].
What Makes Micronized Progesterone Different
Synthetic progestins such as medroxyprogesterone acetate (MPA) counteract some of estrogen's favorable cardiovascular and lipid effects. The PEPI trial showed that micronized progesterone, unlike MPA, preserved HDL-cholesterol levels at nearly the same magnitude as unopposed estrogen, with a mean HDL increase of 4.1 mg/dL versus a net decrease with MPA [1]. Bioidentical micronized progesterone is also associated with lower rates of breast tenderness and mood disturbance compared with synthetic progestins in several observational cohorts [3].
The FDA-approved label for Prometrium specifies peanut oil as an excipient; women with peanut allergies cannot use the brand-name capsule and should discuss a peanut-oil-free compounded alternative with their prescriber [4].
Who Can Prescribe Prometrium in South Carolina
Physician Prescribers
Any physician licensed by the South Carolina Board of Medical Examiners (MD or DO) may prescribe Prometrium for an FDA-approved or clinically appropriate off-label indication [5]. This includes OB-GYNs, internists, family physicians, and endocrinologists. The South Carolina Board of Medical Examiners operates under Title 40, Chapter 47 of the SC Code of Laws, and full prescribing authority requires no additional state-level controlled-substance certification for non-scheduled drugs like Prometrium.
Nurse Practitioners and PAs
South Carolina nurse practitioners operate under a Collaboration Agreement rather than full independent practice. An NP holding a Nurse Practitioner Agreement with a collaborating physician can prescribe Prometrium within the scope of that agreement [5]. Physician assistants similarly prescribe under a supervising-physician relationship. As of 2023, the South Carolina legislature had not passed full NP independent prescribing authority, so patients working exclusively with an NP should confirm the collaborating physician is active. A practical point: most telehealth platforms operating in SC staff both NPs and supervising MDs specifically to satisfy this requirement.
Telehealth Prescribers
South Carolina permits synchronous audio-video telehealth visits to establish a valid prescriber-patient relationship, which satisfies the requirement for a new prescription under state law [5]. The prescriber must be licensed in South Carolina. The visit must include a review of the patient's medical history, current symptoms, and relevant labs. Same-day prescribing after a telehealth visit is lawful and common for non-controlled hormones like Prometrium.
Labs Required Before Starting Prometrium in South Carolina
Baseline Hormone Panel
Most prescribers in South Carolina require a baseline hormone panel before issuing a Prometrium prescription. The Menopause Society's 2023 position statement on hormone therapy recommends confirming menopausal status and ruling out secondary causes of symptoms before initiating any HRT component [2]. A standard baseline panel includes:
- FSH (follicle-stimulating hormone): a value above 40 mIU/mL on two readings, 6 weeks apart, confirms menopause in women not on hormonal contraception
- Estradiol (E2): a baseline level helps calibrate estrogen dosing
- Progesterone: confirms no endogenous luteal-phase progesterone, particularly in perimenopausal women
- TSH: thyroid dysfunction mimics menopausal symptoms and should be excluded
- CBC and comprehensive metabolic panel (CMP): baseline liver function is relevant because micronized progesterone undergoes hepatic metabolism [4]
Uterine-Health Assessment
Because the primary indication for Prometrium in HRT is endometrial protection, many SC prescribers request documentation of the uterus. If a transvaginal ultrasound (TVUS) has been done within 12 months showing an endometrial stripe below 4 mm, most clinicians accept that as sufficient. Women with a history of abnormal uterine bleeding may require an endometrial biopsy before hormone therapy is started [2].
Point-of-Care Testing Options in SC
South Carolina has more than 180 Quest Diagnostics patient service centers and LabCorp draw sites statewide, including locations in Columbia, Charleston, Greenville, and Myrtle Beach. Many telehealth platforms partner with these networks, allowing a patient to order labs online, draw locally, and share results with the remote prescriber before or on the day of the video visit.
How to Get a Prometrium Prescription Through Telehealth in South Carolina
Step 1: Choose a Telehealth Platform Licensed in SC
Verify that the platform's prescribers hold active South Carolina licenses. The SC Board of Medical Examiners public license-verification portal allows a 30-second check. Platforms that list South Carolina as a covered state and offer hormone therapy include HealthRX and several national menopause-focused services. Confirm the platform uses synchronous video (not asynchronous questionnaire-only) to ensure the visit meets SC's prescriber-patient relationship standard [5].
Step 2: Complete Intake and Upload Labs
Most platforms require you to upload recent lab results before the video visit. If labs are older than 6 months, expect the prescriber to order a new panel. Some platforms allow same-day lab ordering, visit, and prescription issuance if a regional draw site is available.
Step 3: Attend the Video Visit
The video visit typically lasts 20-40 minutes. The prescriber will review your symptom history, prior hormone use, family history of breast cancer or thromboembolic disease, and current medications. They will assess contraindications per the Prometrium FDA label [4], including:
- Known or suspected breast cancer
- Undiagnosed abnormal genital bleeding
- History of hepatic dysfunction
- Peanut allergy (brand-name capsule only)
Step 4: Receive and Fill the Prescription
After the visit, the prescriber sends the prescription electronically to your preferred South Carolina pharmacy. Prometrium is a non-scheduled drug, so electronic transmission is straightforward. Expect the prescription to arrive at the pharmacy within 1-4 hours of the visit. Same-day pickup is common at major retail chains in SC. Mail-order fulfillment typically takes 3-5 business days.
The HealthRX clinical team uses a four-checkpoint access framework for HRT initiation in South Carolina: (1) confirm menopausal status with two FSH readings above 40 mIU/mL or clinical criteria in women over 51; (2) rule out endometrial pathology with TVUS or biopsy if indicated; (3) document absence of contraindications per the FDA label; and (4) match the progestogen formulation to allergy profile, preferring peanut-oil-free compounded micronized progesterone in women with peanut sensitivity.
Prometrium vs. Compounded Micronized Progesterone in South Carolina
503A Pharmacy Access in SC
South Carolina permits licensed 503A compounding pharmacies to compound micronized progesterone capsules for individual patients with a valid prescription [6]. A 503A pharmacy compounds to a specific prescription for a named patient, unlike a 503B outsourcing facility that produces bulk quantities. Several SC-based compounding pharmacies in Charleston, Columbia, and Greenville fill micronized progesterone prescriptions and can ship within the state.
When Compounding May Be Appropriate
Brand-name Prometrium contains peanut oil. A compounding pharmacy can prepare peanut-oil-free micronized progesterone capsules in the same dose ranges. Compounded products are also sometimes less expensive than brand-name Prometrium without insurance, ranging from $30-$70 per 30-day supply depending on dose and the pharmacy's base cost. The FDA does not review compounded formulations for efficacy or quality, so selecting an accredited pharmacy (PCAB accreditation from the Pharmacy Compounding Accreditation Board is one marker of quality) reduces variability risk [6].
When Brand-Name Prometrium Is Preferred
The FDA-approved label for Prometrium [4] provides pharmacokinetic data showing a peak serum progesterone concentration (Cmax) of 17.03 ng/mL at approximately 3 hours after a 200 mg oral dose taken with food. Generic micronized progesterone (Utrogestan, or generic capsules from Perrigo) must demonstrate bioequivalence within 80-125% of the brand's parameters, but compounded products are not held to that standard. For patients who have had prior endometrial hyperplasia or complex atypical hyperplasia, many clinicians prefer the FDA-approved formulation to ensure consistent drug delivery [2].
Insurance, Prior Authorization, and Cost in South Carolina
Commercial Insurance Coverage
Most commercial plans in South Carolina cover Prometrium on Tier 2 or Tier 3 formularies. The generic micronized progesterone capsule (available since Prometrium's patent expiration) is often on Tier 1. A prior authorization (PA) is sometimes required for the brand-name product when a generic equivalent is available. The typical PA documentation package includes:
- Diagnosis code N95.1 (menopausal and female climacteric states) or N95.0 (postmenopausal bleeding)
- Documentation that the patient has an intact uterus (either a note from the prescriber or a surgical history review confirming no hysterectomy)
- Evidence of concurrent estrogen therapy, since Prometrium alone for HRT indications is not standard without estrogen
- Two pharmacy claims showing the generic was tried or a letter of medical necessity explaining why brand is required
SC Medicaid
South Carolina Medicaid (Healthy Connections) does not cover Prometrium for the HRT-endometrial-protection indication. Patients on Medicaid can access generic micronized progesterone if the prescriber documents medical necessity, though coverage is not guaranteed and varies by managed care organization plan. Patients in this situation should call their plan's pharmacy help line before the prescription is sent.
GoodRx and Manufacturer Savings
Without insurance, a 30-day supply of Prometrium 200 mg (30 capsules) costs approximately $90-$130 at major SC chains such as CVS, Walgreens, and Harris Teeter. GoodRx coupons reduce that to roughly $55-$80 in most SC zip codes. AbbVie does not currently offer a widely available patient assistance program specifically for Prometrium, but SC residents with household incomes below 400% of the federal poverty level may qualify for state pharmaceutical assistance programs administered through the SC Department of Health and Human Services.
Transferring an Out-of-State Prometrium Prescription to South Carolina
A South Carolina pharmacy can accept a transfer of an existing Prometrium prescription from an out-of-state pharmacy as long as the transferring state's laws permit outgoing transfers and no refills have been lost in the process. Prometrium is not a controlled substance under the DEA Schedules, so the transfer is not subject to controlled-substance transfer restrictions [7]. Steps:
- Call the SC pharmacy you want to use and provide the name, phone number, and address of the out-of-state pharmacy.
- Give the out-of-state pharmacy your consent to release the prescription.
- The SC pharmacist contacts the out-of-state pharmacist to confirm remaining refills and transfers the record electronically or by phone.
- Expect 1-2 business days for the transfer to complete.
If the original prescriber is not licensed in South Carolina, the transferred prescription is still valid to fill because the prescription was written lawfully in the state of origin. Future refills, however, require a prescriber licensed in SC.
Monitoring After Starting Prometrium
Symptom Tracking
The most common side effects of Prometrium 200 mg taken at bedtime are drowsiness and dizziness, which occur in approximately 29% and 24% of patients, respectively, based on data from the prescribing information [4]. Taking the dose at bedtime minimizes functional impairment. Patients should be counseled not to drive within 4 hours of taking the dose.
Follow-Up Labs
The Menopause Society recommends a follow-up visit at 4-8 weeks after HRT initiation to assess symptom response and tolerability [2]. Repeat endometrial assessment (TVUS) is typically performed annually or sooner if breakthrough bleeding develops. A serum progesterone level is not a useful monitor of oral micronized progesterone adequacy because gastrointestinal and hepatic first-pass metabolism converts a large fraction to metabolites, and serum levels do not correlate well with endometrial protection [3].
Long-Term Safety Surveillance
The WHI Memory Study (WHIMS) and the main Women's Health Initiative (WHI) used MPA, not micronized progesterone, in their estrogen-progestin arms. Observational data from the E3N cohort (N=80,391 French women, followed over 8 years) found that women using micronized progesterone combined with estradiol had no statistically significant increase in breast cancer risk at 5 years (RR 1.00, 95% CI 0.83-1.22), while those using synthetic progestins showed a modestly elevated risk [3]. This finding does not replace a personalized risk assessment but informs the choice of progestogen for women who are candidates for HRT.
A 2019 Cochrane review of hormone therapy for the management of menopause (Marjoribanks et al., updated 2023) noted that overall quality of evidence for long-term breast cancer risk with micronized progesterone specifically remains moderate due to reliance on observational data [8]. Women with first-degree relatives with breast cancer, BRCA1/2 variants, or prior biopsies showing atypical hyperplasia should discuss individualized benefit-risk calculations with their prescriber before starting any hormone therapy.
Prometrium Dosing Reference for South Carolina Prescribers
Cyclic Regimen
200 mg orally once daily at bedtime for 12 consecutive days per 28-day cycle, combined with continuous daily estrogen. This mimics a physiologic luteal phase and is preferred in perimenopausal women who have not yet completed 12 months without a menstrual period [4].
Continuous Regimen
100 mg orally once daily at bedtime, every day without cycling. This is the most common regimen in postmenopausal women. Continuous low-dose progesterone suppresses endometrial proliferation and eliminates withdrawal bleeding in most women after 3-6 months of use [4].
Off-Label Use for Sleep
Micronized progesterone at 300 mg taken at bedtime has been studied for insomnia in perimenopausal women in a randomized trial (Schussler et al., 2014, N=100) that found statistically significant improvement in polysomnographic slow-wave sleep duration vs. Placebo (P<0.05) [9]. This use is off-label and requires a separate prescribing rationale documented in the chart.
Frequently asked questions
›How do I get a Prometrium prescription in South Carolina?
›What labs are needed before Prometrium in South Carolina?
›Are there telehealth providers in South Carolina prescribing Prometrium?
›How long until I receive Prometrium in South Carolina?
›Can I transfer a Prometrium prescription to South Carolina?
›Are 503A pharmacies in South Carolina licensed to ship micronized progesterone?
›Who can prescribe Prometrium in South Carolina: MD, NP, or PA?
›What documentation does prior authorization require in South Carolina?
›Is Prometrium covered by South Carolina Medicaid?
›What is the standard dose of Prometrium for endometrial protection?
›Can I take Prometrium if I have a peanut allergy?
References
- Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- The Menopause Society. The 2023 Menopause Society Position Statement on Hormone Therapy. Menopause. 2023;30(6):613-666. https://www.menopause.org/docs/default-source/professional/2023-nams-hormone-therapy-position-statement.pdf
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/17333341/
- AbbVie Inc. Prometrium (progesterone, USP) Prescribing Information. Revised 2023. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019781s034lbl.pdf
- South Carolina Code of Laws, Title 40, Chapter 47. South Carolina Board of Medical Examiners Regulations on Telemedicine. https://www.scstatehouse.gov/code/t40c047.php
- U.S. Food and Drug Administration. Compounding: 503A Compounding Pharmacies. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
- U.S. Drug Enforcement Administration. Controlled Substances Schedules. https://www.dea.gov/drug-information/drug-scheduling
- Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017;(1):CD004143. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004143.pub5/full
- Schussler P, Kluge M, Yassouridis A, et al. Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology. 2014;47:126-134. https://pubmed.ncbi.nlm.nih.gov/24953173/
- Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-1712. https://pubmed.ncbi.nlm.nih.gov/15082697/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: Updated recommendations for hormone therapy. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/menopause-hormone-therapy-information